Evidence map›Paper›PMID 32512887›Full record

ReviewInternational journal of molecular sciences2020

Regulation of Deubiquitinating Enzymes by Post-Translational Modifications.

Tanuza Das, Sang Chul Shin, Eun Joo Song, Eunice EunKyeong Kim

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. [Ubiquitin-specific protease 42 regulates osteogenic differentiation of human adipose-derived stem cells].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2024
    Article
  13. Article
  14. Deubiquitinases in cancer.Nature reviews. Cancer · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tanuza DasBiomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea.
Sang Chul ShinBiomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea.
Eun Joo SongGraduate School of Pharmaceutical Sciences and College of Pharmacy, Ewha Womans University, Seoul 03760, Korea.ORCID 0000-0002-2420-6666
Eunice EunKyeong KimBiomedical Research Institute, Korea Institute of Science and Technology, Seoul 02792, Korea.ORCID 0000-0002-7707-8055
Korea Institute of Science and Technology · KREwha Womans University · KR

Funding

National Research Foundation of Korea 2017R1A2B3007224 and 2019R1A2C2004052
6 · The paper itself

Abstract

Ubiquitination and deubiquitination play a critical role in all aspects of cellular processes, and the enzymes involved are tightly regulated by multiple factors including posttranslational modifications like most other proteins. Dysfunction or misregulation of these enzymes could have dramatic physiological consequences, sometimes leading to diseases. Therefore, it is important to have a clear understanding of these regulatory processes. Here, we have reviewed the posttranslational modifications of deubiquitinating enzymes and their consequences on the catalytic activity, stability, abundance, localization, and interaction with the partner proteins.

Indexed as

Protein Processing, Post-TranslationalCatalysisDeubiquitinating EnzymesHumansPhosphorylationProtein TransportUbiquitinUbiquitinationDeubiquitinating EnzymesUbiquitinactivitydeubiquitinase (DUB)deubiquitinating enzymediseaseinteractionlocalizationpost-translational modification (PTM)

Identifiers

PMID32512887
PMCPMC7312083
OpenAlexW3033892078

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.